AHA 2022: Adverse Cardiovascular Outcomes in HF With Preserved Systolic Function Associated With Atrial Fibrillation Are Due to Loss of Rhythm Control Impacting HF Status
By
AHA 2022 Conference Coverage
FEATURING
Sanjeev Saksena
November 14, 2022
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
Wed, May 18, 2022
Faculty: Roderick Tung , Dhiraj Gupta , Boston Scientific , Brad Sutton , Wilber Su , Ignacio Garcia-Bolao
Faculty: Roderick Tung , Dhiraj Gupta , Boston Scientific , Brad Sutton , Wilber Su , Ignacio Garcia-Bolao